DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management

Increasing evidence suggested DNA methylation may serve as potential prognostic biomarkers; however, few related DNA methylation signatures have been established for prediction of lung cancer prognosis. We aimed at developing DNA methylation signature to improve prognosis prediction of stage I lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xianxiong, Cheng, Jiancheng, Zhao, Peng, Li, Lei, Tao, Kaixiong, Chen, Hengyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339160/
https://www.ncbi.nlm.nih.gov/pubmed/32530136
http://dx.doi.org/10.1111/jcmm.15393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339160/
https://www.ncbi.nlm.nih.gov/pubmed/32530136
http://dx.doi.org/10.1111/jcmm.15393

Ejemplares similares